April 20, 2020 – Looking forward, global economies are relying on the pharmaceutical industry to produce solutions, and many of the companies on this list are involved in the race for vaccines and drugs. We’ll continue tracking their performance—and potential advances in COVID-19—as the year plays out.
Some notes: Though BMS closed its Celgene deal in late 2019, it won’t leap ahead in our rankings till next year, when the combined company’s 2020 numbers are in. AbbVie is set to jump in the rankings as well, thanks to its massive purchase of Allergan, provided the deal closes later this year as scheduled.
In the meantime, please enjoy this year’s edition, and feel free to reach out with any comments.
EMR MATTERS – October 2024 - The challenge is that many in the behavioral health…
TOO LITTLE, TOO LATE? – Dec. 19, 2024 - Assembly Bill 56 (AB 56) proposes…
AND STOPPED DIGGING – Dec. 4, 2024 - In a new interview with The Times,…
NOT JUST IN PENCILS – Dec. 8, 2024 - Americans born before 1966 experienced “significantly…
AS SUCCESSFUL AS EVER – Dec. 3, 2024 - Family Affair actor Johnny Whitaker looked…
ALANON Plus – Dec. 7, 2024 - A high percentage of treatment failures occur due…